![](/img/cover-not-exists.png)
Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer?
Chappell, Nicole P., Miller, Caela R., Fielden, Aaron D., Barnett, Jason C.Volume:
12
Journal:
Journal of Oncology Practice
DOI:
10.1200/jop.2015.010470
Date:
July, 2016
File:
PDF, 1.50 MB
2016